Table 1.
Group | Genotype | Histology | Median survival (week) |
---|---|---|---|
A0 | p48-Cre; LSL-KRASG12D | PanIN | 46.79 |
A1 | p48-Cre; LSL-KRASG12D; HMMRΔexon8-16/WT | PanIN | undefined |
A2 | p48-Cre; LSL-KRASG12D; HMMRΔexon8-16/Δexon8-16 | PanIN | 48.86 |
B0 | p48-Cre; LSL-KRASG12D; p53lox/+ | PDAC | 23.93 |
B1 | p48-Cre; LSL-KRASG12D; p53lox/+; HMMRΔexon8-16/WT | PDAC | 17.50 |
B2 | p48-Cre; LSL-KRASG12D; p53lox/+; HMMRΔexon8-16/Δexon8-16 | PDAC | 15.41 |
C0 | p48-Cre; LSL-KRASG12D; p53lox/lox | PDAC | 9.14 |
C1 | p48-Cre; LSL-KRASG12D; p53lox/lox; HMMRΔexon8-16/WT | PDAC | 9.86 |
C2 | p48-Cre; LSL-KRASG12D; p53lox/lox; HMMRΔexon8-16/Δexon8-16 | PDAC | 9.57 |
T0 | RIP-Tag | PNET | 17.57 |
T1 | RIP-Tag; HMMRΔexon8-16/WT | PNET | 16.14 |
T2 | RIP-Tag; HMMRΔexon8-16/Δexon8-16 | PNET | 15.50 |